Login / Signup

Prognostic significance of high mobility group A2 (HMGA2) in pancreatic ductal adenocarcinoma: malignant functions of cytoplasmic HMGA2 expression.

Jan-Paul GundlachCharlotte HauserFranka Maria SchlegelAnna WillmsChristine HalskeChristian RöderSandra KrügerChristoph RöckenThomas BeckerHolger KalthoffAnna Trauzold
Published in: Journal of cancer research and clinical oncology (2021)
HMGA2 is a prognostic marker in PDAC. Firstly, we found a positive correlation for cytoplasmic HMGA2 expression with lympho-vascular invasion and, secondly, we found a significantly stronger nuclear expression of HMGA2 in cancer-positive lymph node nuclei compared to primary tumor cell nuclei. So far, the role of cytoplasmic HMGA2 is nearly unknown, however, our data lend support to the hypothesis that cytoplasmic HMGA2 expression is involved in nodal spread.
Keyphrases
  • poor prognosis
  • lymph node
  • binding protein
  • long non coding rna
  • stem cells
  • squamous cell carcinoma
  • single cell
  • radiation therapy
  • cell therapy
  • papillary thyroid